Operating Income: The income after operating expenses.
Edwards Lifesciences Corporation (EW) had Operating Income of $307.10M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.55B |
|
$291.10M |
|
$345.20M |
|
$1.21B |
|
$1.25B |
|
|
Operating Income |
$307.10M |
$41.30M |
|
$348.40M |
|
$348.40M |
|
$292.30M |
|
$292.30M |
|
$290.30M |
|
$292.30M |
|
$307.10M |
|
$346.30M |
|
584.70M |
|
585.70M |
|
$0.50 |
|
$0.50 |
|
| Balance Sheet Financials | |
$6.36B |
|
$1.74B |
|
$6.91B |
|
$13.27B |
|
$1.59B |
|
$598.20M |
|
$1.48B |
|
$3.07B |
|
$10.21B |
|
$7.31B |
|
$10.21B |
|
580.70M |
|
| Cash Flow Statement Financials | |
$1.14B |
|
$-514.60M |
|
$-945.40M |
|
$3.06B |
|
$2.69B |
|
$-364.00M |
|
$118.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.00 |
|
-- |
|
-- |
|
0.06 |
|
0.06 |
|
77.77% |
|
19.77% |
|
19.77% |
|
-- |
|
22.43% |
|
18.74% |
|
$981.50M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.30 |
|
1.74 |
|
51.74 |
|
2.86% |
|
4.00% |
|
2.20% |
|
2.71% |
|
$17.57 |
|
$1.68 |
|
$1.95 |
|